Table 4. Joint effect of MTHFR C677T and plasma folate concentration on PBMC L1 methylation among non-cases.
MTHFR C677T and folatecombination | Number of women with PBMC L1Methylation ≥68.5%/<68.5% | OR (95% CI) | P-value* |
CT+TT & folate ≥11.21 ng/mL | 22/21 | 1.00 (ref) | |
CT+TT & folate <11.21 ng/mL | 8/32 | 0.28 (0.09–0.78) | 0.017 |
CC & folate ≥11.21 ng/mL | 39/77 | 0.55 (0.24–1.25) | 0.151 |
CC & folate <11.21 ng/mL | 35/79 | 0.63 (0.27–1.47) | 0.285 |
P-value for interaction | 0.030 |
*Adjusted for age, self-reported race, level of education, BMI, physical activity smoking status, parity, use of oral/hormone contraceptive and circulating concentrations of vitamin C, total carotene and vitamin B12.